Efficacy, Safety and Tolerability of DNK333 (25 mg Bid) in Women With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)
Public ClinicalTrials.gov record NCT00394173. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of DNK333 25mg b.i.d. Given Orally for 4 Weeks in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)
Study identification
- NCT ID
- NCT00394173
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Novartis
- Industry
- Enrollment
- 180 participants
Conditions and interventions
Interventions
- DNK333 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- Female
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2006
- Primary completion
- Sep 30, 2007
- Completion
- Sep 30, 2007
- Last update posted
- Feb 26, 2017
2006 – 2007
United States locations
- U.S. sites
- 37
- U.S. states
- 19
- U.S. cities
- 37
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigative Site | Tucson | Arizona | 85712 | — |
| Investigative Site | North Little Rock | Arkansas | 72114 | — |
| Investigative Site | Los Angeles | California | 90045-3119 | — |
| Investigative Site | Orange | California | 92869 | — |
| Investigative Site | Riverside | California | 92506 | — |
| Investigative Site | Sacramento | California | 95825 | — |
| Investigative Site | San Diego | California | 92108 | — |
| Investigative Site | Colorado Springs | Colorado | 80904 | — |
| Investigative Site | Bristol | Connecticut | 06010 | — |
| Investigative Site | Hartford | Connecticut | 06010 | — |
| Investigative Site | Boca Raton | Florida | 33486 | — |
| Investigative Site | Gainesville | Florida | 32256 | — |
| Investigative Site | Hollywood | Florida | 33021 | — |
| Investigative Site | Jacksonville | Florida | 782091744 | — |
| Investigative Site | Miami | Florida | 33173 | — |
| Investigative Site | New Smyrna Beach | Florida | 32168-7327 | — |
| Investigative Site | Tampa | Florida | 33607 | — |
| Investigative Site | Arlington Heights | Illinois | 60005 | — |
| Investigative Site | Rockford | Illinois | 61107 | — |
| Investigative Site | Boston | Massachusetts | 02215 | — |
| Investigative Site | Wellesley Hills | Massachusetts | 02481-2106 | — |
| Investigative Site | Mexico | Missouri | 65265-3726 | — |
| Investigative Site | Buffalo | New York | 14215 | — |
| Investigative Site | Great Neck | New York | 11023-2432 | — |
| Investigative Site | Elkin | North Carolina | 28621 | — |
| Investigative Site | Cincinnati | Ohio | 45219 | — |
| Investigative Site | Oklahoma City | Oklahoma | 73104 | — |
| Investigative Site | Portland | Oregon | 97220 | — |
| Investigative Site | Chattanooga | Tennessee | 37404 | — |
| Investigative Site | Lake Jackson | Texas | 77566 | — |
| Investigative Site | San Antonio | Texas | 78209-1744 | — |
| Investigative Site | Salt Lake City | Utah | 84102 | — |
| Investigative Site | Chesapeake | Virginia | 23320-1706 | — |
| Investigative Site | Bellevue | Washington | 98004 | — |
| Investigative Site | Everett | Washington | 98208 | — |
| Investigative Site | Monroe | Washington | 98208 | — |
| Investigative Site | Seattle | Washington | 98101 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00394173, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 26, 2017 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00394173 live on ClinicalTrials.gov.